JENNIFER HARLACHER: Open Payments
NPI 1326685975 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,799 in 98 payments from 19 companies in 2025. Trend: 2023 $1,428 · 2024 $1,884 · 2025 $1,799
Food & beverage: $1,799
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK INC. | 12 | $189 |
| Novartis Pharmaceuticals Corporation | 15 | $187 |
| PFIZER INC. | 9 | $179 |
| Amgen Inc. | 14 | $166 |
| Novo Nordisk Inc | 7 | $165 |
| Esperion Therapeutics, Inc. | 8 | $141 |
| CVRx, Inc. | 6 | $138 |
| Lilly USA, LLC | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| Merck Sharp & Dohme LLC | 3 | $74 |
Products named: LEQVIO, REPATHA, VYNDAQEL, NEXLETOL, Barostim Neo System, Wegovy, VERQUVO, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
